nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—INSR—Parkinson's disease	0.212	0.305	CbGaD
Sunitinib—STK39—Parkinson's disease	0.212	0.305	CbGaD
Sunitinib—MERTK—Parkinson's disease	0.137	0.197	CbGaD
Sunitinib—LRRK2—Parkinson's disease	0.122	0.175	CbGaD
Sunitinib—ABCB1—Parkinson's disease	0.0118	0.017	CbGaD
Sunitinib—Metoclopramide—DRD3—Parkinson's disease	0.000934	0.401	CrCbGaD
Sunitinib—Metoclopramide—DRD2—Parkinson's disease	0.000647	0.278	CrCbGaD
Sunitinib—Metoclopramide—CYP2D6—Parkinson's disease	0.000457	0.196	CrCbGaD
Sunitinib—Procainamide—CYP2D6—Parkinson's disease	0.00029	0.125	CrCbGaD
Sunitinib—ULK3—head—Parkinson's disease	0.0001	0.000789	CbGeAlD
Sunitinib—MAP2K2—head—Parkinson's disease	0.0001	0.000789	CbGeAlD
Sunitinib—FYN—midbrain—Parkinson's disease	0.0001	0.000789	CbGeAlD
Sunitinib—CAMK2G—central nervous system—Parkinson's disease	0.0001	0.000788	CbGeAlD
Sunitinib—BMP2K—central nervous system—Parkinson's disease	0.0001	0.000788	CbGeAlD
Sunitinib—CSF1R—cardiovascular system—Parkinson's disease	0.0001	0.000787	CbGeAlD
Sunitinib—FGFR2—spinal cord—Parkinson's disease	9.96e-05	0.000784	CbGeAlD
Sunitinib—CLK1—cerebellum—Parkinson's disease	9.96e-05	0.000784	CbGeAlD
Sunitinib—STK16—brain—Parkinson's disease	9.95e-05	0.000784	CbGeAlD
Sunitinib—MAP3K2—head—Parkinson's disease	9.95e-05	0.000783	CbGeAlD
Sunitinib—LRRK2—central nervous system—Parkinson's disease	9.91e-05	0.000781	CbGeAlD
Sunitinib—JAK2—spinal cord—Parkinson's disease	9.91e-05	0.00078	CbGeAlD
Sunitinib—HIPK2—brain—Parkinson's disease	9.9e-05	0.00078	CbGeAlD
Sunitinib—HIPK3—brain—Parkinson's disease	9.9e-05	0.00078	CbGeAlD
Sunitinib—ALK—brain—Parkinson's disease	9.9e-05	0.00078	CbGeAlD
Sunitinib—TYRO3—brain—Parkinson's disease	9.9e-05	0.00078	CbGeAlD
Sunitinib—YES1—medulla oblongata—Parkinson's disease	9.89e-05	0.000779	CbGeAlD
Sunitinib—CSNK1E—nervous system—Parkinson's disease	9.87e-05	0.000777	CbGeAlD
Sunitinib—TNK1—brain—Parkinson's disease	9.8e-05	0.000772	CbGeAlD
Sunitinib—RIOK2—brain—Parkinson's disease	9.8e-05	0.000772	CbGeAlD
Sunitinib—MAP4K5—midbrain—Parkinson's disease	9.79e-05	0.000771	CbGeAlD
Sunitinib—MAP3K3—midbrain—Parkinson's disease	9.79e-05	0.000771	CbGeAlD
Sunitinib—CAMK2G—cerebellum—Parkinson's disease	9.78e-05	0.00077	CbGeAlD
Sunitinib—BMP2K—cerebellum—Parkinson's disease	9.78e-05	0.00077	CbGeAlD
Sunitinib—FYN—spinal cord—Parkinson's disease	9.77e-05	0.000769	CbGeAlD
Sunitinib—PRKAA1—central nervous system—Parkinson's disease	9.77e-05	0.000769	CbGeAlD
Sunitinib—TAOK3—medulla oblongata—Parkinson's disease	9.76e-05	0.000769	CbGeAlD
Sunitinib—TBK1—head—Parkinson's disease	9.74e-05	0.000767	CbGeAlD
Sunitinib—IRAK4—nervous system—Parkinson's disease	9.72e-05	0.000765	CbGeAlD
Sunitinib—MAP3K19—brain—Parkinson's disease	9.7e-05	0.000764	CbGeAlD
Sunitinib—MAP4K1—brain—Parkinson's disease	9.7e-05	0.000764	CbGeAlD
Sunitinib—LRRK2—cerebellum—Parkinson's disease	9.69e-05	0.000763	CbGeAlD
Sunitinib—TYK2—head—Parkinson's disease	9.68e-05	0.000762	CbGeAlD
Sunitinib—PTK2B—central nervous system—Parkinson's disease	9.66e-05	0.000761	CbGeAlD
Sunitinib—MAP4K5—spinal cord—Parkinson's disease	9.55e-05	0.000752	CbGeAlD
Sunitinib—MAP3K3—spinal cord—Parkinson's disease	9.55e-05	0.000752	CbGeAlD
Sunitinib—PRKAA1—cerebellum—Parkinson's disease	9.55e-05	0.000752	CbGeAlD
Sunitinib—DAPK3—brain—Parkinson's disease	9.51e-05	0.000749	CbGeAlD
Sunitinib—CSNK1E—central nervous system—Parkinson's disease	9.5e-05	0.000748	CbGeAlD
Sunitinib—MAP2K2—nervous system—Parkinson's disease	9.5e-05	0.000748	CbGeAlD
Sunitinib—ULK3—nervous system—Parkinson's disease	9.5e-05	0.000748	CbGeAlD
Sunitinib—FLT1—midbrain—Parkinson's disease	9.46e-05	0.000745	CbGeAlD
Sunitinib—PTK2B—cerebellum—Parkinson's disease	9.44e-05	0.000743	CbGeAlD
Sunitinib—MAP3K2—nervous system—Parkinson's disease	9.43e-05	0.000743	CbGeAlD
Sunitinib—CLK2—brain—Parkinson's disease	9.42e-05	0.000742	CbGeAlD
Sunitinib—MAP4K2—brain—Parkinson's disease	9.38e-05	0.000739	CbGeAlD
Sunitinib—RPS6KB1—head—Parkinson's disease	9.37e-05	0.000738	CbGeAlD
Sunitinib—IRAK4—central nervous system—Parkinson's disease	9.35e-05	0.000737	CbGeAlD
Sunitinib—EPHB6—midbrain—Parkinson's disease	9.35e-05	0.000737	CbGeAlD
Sunitinib—RET—head—Parkinson's disease	9.32e-05	0.000734	CbGeAlD
Sunitinib—FGR—head—Parkinson's disease	9.32e-05	0.000734	CbGeAlD
Sunitinib—CSNK1E—cerebellum—Parkinson's disease	9.29e-05	0.000731	CbGeAlD
Sunitinib—FGFR1—cerebellum—Parkinson's disease	9.29e-05	0.000731	CbGeAlD
Sunitinib—AXL—head—Parkinson's disease	9.28e-05	0.000731	CbGeAlD
Sunitinib—STK3—brain—Parkinson's disease	9.25e-05	0.000729	CbGeAlD
Sunitinib—TBK1—nervous system—Parkinson's disease	9.24e-05	0.000727	CbGeAlD
Sunitinib—FLT1—spinal cord—Parkinson's disease	9.23e-05	0.000727	CbGeAlD
Sunitinib—TYK2—nervous system—Parkinson's disease	9.18e-05	0.000723	CbGeAlD
Sunitinib—ULK3—central nervous system—Parkinson's disease	9.15e-05	0.00072	CbGeAlD
Sunitinib—MAP2K2—central nervous system—Parkinson's disease	9.15e-05	0.00072	CbGeAlD
Sunitinib—IRAK4—cerebellum—Parkinson's disease	9.14e-05	0.00072	CbGeAlD
Sunitinib—ROCK1—brain—Parkinson's disease	9.13e-05	0.000719	CbGeAlD
Sunitinib—EPHB6—spinal cord—Parkinson's disease	9.13e-05	0.000719	CbGeAlD
Sunitinib—MAP3K2—central nervous system—Parkinson's disease	9.08e-05	0.000715	CbGeAlD
Sunitinib—KIT—cardiovascular system—Parkinson's disease	9.08e-05	0.000715	CbGeAlD
Sunitinib—YES1—midbrain—Parkinson's disease	9.04e-05	0.000712	CbGeAlD
Sunitinib—ULK3—cerebellum—Parkinson's disease	8.94e-05	0.000704	CbGeAlD
Sunitinib—MAP2K2—cerebellum—Parkinson's disease	8.94e-05	0.000704	CbGeAlD
Sunitinib—TAOK3—midbrain—Parkinson's disease	8.92e-05	0.000703	CbGeAlD
Sunitinib—DYRK1A—brain—Parkinson's disease	8.91e-05	0.000701	CbGeAlD
Sunitinib—TBK1—central nervous system—Parkinson's disease	8.89e-05	0.0007	CbGeAlD
Sunitinib—RPS6KB1—nervous system—Parkinson's disease	8.89e-05	0.0007	CbGeAlD
Sunitinib—MAP3K2—cerebellum—Parkinson's disease	8.88e-05	0.000699	CbGeAlD
Sunitinib—PDGFRB—cardiovascular system—Parkinson's disease	8.87e-05	0.000698	CbGeAlD
Sunitinib—FGFR2—head—Parkinson's disease	8.85e-05	0.000697	CbGeAlD
Sunitinib—TYK2—central nervous system—Parkinson's disease	8.83e-05	0.000696	CbGeAlD
Sunitinib—RET—nervous system—Parkinson's disease	8.83e-05	0.000696	CbGeAlD
Sunitinib—FGR—nervous system—Parkinson's disease	8.83e-05	0.000696	CbGeAlD
Sunitinib—YES1—spinal cord—Parkinson's disease	8.82e-05	0.000694	CbGeAlD
Sunitinib—JAK2—head—Parkinson's disease	8.81e-05	0.000693	CbGeAlD
Sunitinib—AXL—nervous system—Parkinson's disease	8.8e-05	0.000693	CbGeAlD
Sunitinib—MAP3K7—cerebellum—Parkinson's disease	8.79e-05	0.000692	CbGeAlD
Sunitinib—KDR—medulla oblongata—Parkinson's disease	8.75e-05	0.000689	CbGeAlD
Sunitinib—MAP2K5—medulla oblongata—Parkinson's disease	8.75e-05	0.000689	CbGeAlD
Sunitinib—TAOK3—spinal cord—Parkinson's disease	8.71e-05	0.000686	CbGeAlD
Sunitinib—MERTK—brain—Parkinson's disease	8.7e-05	0.000685	CbGeAlD
Sunitinib—TBK1—cerebellum—Parkinson's disease	8.69e-05	0.000685	CbGeAlD
Sunitinib—FYN—head—Parkinson's disease	8.68e-05	0.000684	CbGeAlD
Sunitinib—PDGFRA—spinal cord—Parkinson's disease	8.65e-05	0.000681	CbGeAlD
Sunitinib—TYK2—cerebellum—Parkinson's disease	8.63e-05	0.00068	CbGeAlD
Sunitinib—RPS6KB1—central nervous system—Parkinson's disease	8.56e-05	0.000674	CbGeAlD
Sunitinib—CSF1R—medulla oblongata—Parkinson's disease	8.54e-05	0.000673	CbGeAlD
Sunitinib—MAP4K4—brain—Parkinson's disease	8.54e-05	0.000673	CbGeAlD
Sunitinib—IRAK1—cerebellum—Parkinson's disease	8.52e-05	0.000671	CbGeAlD
Sunitinib—FGR—central nervous system—Parkinson's disease	8.5e-05	0.00067	CbGeAlD
Sunitinib—RET—central nervous system—Parkinson's disease	8.5e-05	0.00067	CbGeAlD
Sunitinib—MAP4K5—head—Parkinson's disease	8.49e-05	0.000668	CbGeAlD
Sunitinib—MAP3K3—head—Parkinson's disease	8.49e-05	0.000668	CbGeAlD
Sunitinib—NUAK2—brain—Parkinson's disease	8.48e-05	0.000668	CbGeAlD
Sunitinib—AXL—central nervous system—Parkinson's disease	8.47e-05	0.000667	CbGeAlD
Sunitinib—MAP3K12—brain—Parkinson's disease	8.42e-05	0.000663	CbGeAlD
Sunitinib—FGFR2—nervous system—Parkinson's disease	8.39e-05	0.000661	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—Parkinson's disease	8.36e-05	0.000659	CbGeAlD
Sunitinib—ABCC4—forebrain—Parkinson's disease	8.35e-05	0.000657	CbGeAlD
Sunitinib—JAK2—nervous system—Parkinson's disease	8.35e-05	0.000657	CbGeAlD
Sunitinib—RET—cerebellum—Parkinson's disease	8.31e-05	0.000655	CbGeAlD
Sunitinib—RPS6KA3—brain—Parkinson's disease	8.3e-05	0.000654	CbGeAlD
Sunitinib—AXL—cerebellum—Parkinson's disease	8.28e-05	0.000652	CbGeAlD
Sunitinib—MAP2K1—brain—Parkinson's disease	8.25e-05	0.00065	CbGeAlD
Sunitinib—FYN—nervous system—Parkinson's disease	8.23e-05	0.000648	CbGeAlD
Sunitinib—FLT1—head—Parkinson's disease	8.21e-05	0.000646	CbGeAlD
Sunitinib—CSNK1A1—brain—Parkinson's disease	8.14e-05	0.000641	CbGeAlD
Sunitinib—EPHB6—head—Parkinson's disease	8.11e-05	0.000639	CbGeAlD
Sunitinib—CLK1—brain—Parkinson's disease	8.09e-05	0.000637	CbGeAlD
Sunitinib—FGFR2—central nervous system—Parkinson's disease	8.08e-05	0.000636	CbGeAlD
Sunitinib—MAP4K5—nervous system—Parkinson's disease	8.05e-05	0.000634	CbGeAlD
Sunitinib—MAP3K3—nervous system—Parkinson's disease	8.05e-05	0.000634	CbGeAlD
Sunitinib—JAK2—central nervous system—Parkinson's disease	8.04e-05	0.000633	CbGeAlD
Sunitinib—KDR—midbrain—Parkinson's disease	8e-05	0.00063	CbGeAlD
Sunitinib—MAP2K5—midbrain—Parkinson's disease	8e-05	0.00063	CbGeAlD
Sunitinib—SLK—cerebellum—Parkinson's disease	7.97e-05	0.000628	CbGeAlD
Sunitinib—BMP2K—brain—Parkinson's disease	7.94e-05	0.000625	CbGeAlD
Sunitinib—CAMK2G—brain—Parkinson's disease	7.94e-05	0.000625	CbGeAlD
Sunitinib—FYN—central nervous system—Parkinson's disease	7.93e-05	0.000624	CbGeAlD
Sunitinib—FGFR2—cerebellum—Parkinson's disease	7.9e-05	0.000622	CbGeAlD
Sunitinib—LRRK2—brain—Parkinson's disease	7.87e-05	0.00062	CbGeAlD
Sunitinib—JAK2—cerebellum—Parkinson's disease	7.86e-05	0.000619	CbGeAlD
Sunitinib—YES1—head—Parkinson's disease	7.84e-05	0.000617	CbGeAlD
Sunitinib—CSF1R—midbrain—Parkinson's disease	7.81e-05	0.000615	CbGeAlD
Sunitinib—KDR—spinal cord—Parkinson's disease	7.8e-05	0.000615	CbGeAlD
Sunitinib—MAP2K5—spinal cord—Parkinson's disease	7.8e-05	0.000615	CbGeAlD
Sunitinib—FLT1—nervous system—Parkinson's disease	7.78e-05	0.000613	CbGeAlD
Sunitinib—STK10—head—Parkinson's disease	7.77e-05	0.000612	CbGeAlD
Sunitinib—KIT—medulla oblongata—Parkinson's disease	7.76e-05	0.000611	CbGeAlD
Sunitinib—PRKAA1—brain—Parkinson's disease	7.76e-05	0.000611	CbGeAlD
Sunitinib—FYN—cerebellum—Parkinson's disease	7.75e-05	0.00061	CbGeAlD
Sunitinib—MAP4K5—central nervous system—Parkinson's disease	7.75e-05	0.00061	CbGeAlD
Sunitinib—MAP3K3—central nervous system—Parkinson's disease	7.75e-05	0.00061	CbGeAlD
Sunitinib—TAOK3—head—Parkinson's disease	7.74e-05	0.000609	CbGeAlD
Sunitinib—EPHB6—nervous system—Parkinson's disease	7.69e-05	0.000606	CbGeAlD
Sunitinib—PDGFRA—head—Parkinson's disease	7.69e-05	0.000605	CbGeAlD
Sunitinib—PTK2B—brain—Parkinson's disease	7.67e-05	0.000604	CbGeAlD
Sunitinib—FLT4—brain—Parkinson's disease	7.65e-05	0.000602	CbGeAlD
Sunitinib—CSF1R—spinal cord—Parkinson's disease	7.62e-05	0.0006	CbGeAlD
Sunitinib—PDGFRB—medulla oblongata—Parkinson's disease	7.58e-05	0.000597	CbGeAlD
Sunitinib—MAP4K5—cerebellum—Parkinson's disease	7.57e-05	0.000596	CbGeAlD
Sunitinib—MAP3K3—cerebellum—Parkinson's disease	7.57e-05	0.000596	CbGeAlD
Sunitinib—CSNK1E—brain—Parkinson's disease	7.54e-05	0.000594	CbGeAlD
Sunitinib—FGFR1—brain—Parkinson's disease	7.54e-05	0.000594	CbGeAlD
Sunitinib—FLT1—central nervous system—Parkinson's disease	7.49e-05	0.00059	CbGeAlD
Sunitinib—YES1—nervous system—Parkinson's disease	7.43e-05	0.000585	CbGeAlD
Sunitinib—IRAK4—brain—Parkinson's disease	7.43e-05	0.000585	CbGeAlD
Sunitinib—EPHB6—central nervous system—Parkinson's disease	7.4e-05	0.000583	CbGeAlD
Sunitinib—STK10—nervous system—Parkinson's disease	7.36e-05	0.00058	CbGeAlD
Sunitinib—TAOK3—nervous system—Parkinson's disease	7.34e-05	0.000578	CbGeAlD
Sunitinib—FLT1—cerebellum—Parkinson's disease	7.32e-05	0.000576	CbGeAlD
Sunitinib—PDGFRA—nervous system—Parkinson's disease	7.29e-05	0.000574	CbGeAlD
Sunitinib—MAP2K2—brain—Parkinson's disease	7.26e-05	0.000572	CbGeAlD
Sunitinib—ULK3—brain—Parkinson's disease	7.26e-05	0.000572	CbGeAlD
Sunitinib—EPHB6—cerebellum—Parkinson's disease	7.24e-05	0.00057	CbGeAlD
Sunitinib—MAP3K2—brain—Parkinson's disease	7.21e-05	0.000568	CbGeAlD
Sunitinib—YES1—central nervous system—Parkinson's disease	7.15e-05	0.000563	CbGeAlD
Sunitinib—MAP3K7—brain—Parkinson's disease	7.14e-05	0.000562	CbGeAlD
Sunitinib—STK10—central nervous system—Parkinson's disease	7.09e-05	0.000558	CbGeAlD
Sunitinib—KIT—midbrain—Parkinson's disease	7.09e-05	0.000558	CbGeAlD
Sunitinib—TAOK3—central nervous system—Parkinson's disease	7.06e-05	0.000556	CbGeAlD
Sunitinib—TBK1—brain—Parkinson's disease	7.06e-05	0.000556	CbGeAlD
Sunitinib—PDGFRA—central nervous system—Parkinson's disease	7.02e-05	0.000553	CbGeAlD
Sunitinib—TYK2—brain—Parkinson's disease	7.01e-05	0.000552	CbGeAlD
Sunitinib—YES1—cerebellum—Parkinson's disease	6.99e-05	0.000551	CbGeAlD
Sunitinib—KDR—head—Parkinson's disease	6.94e-05	0.000546	CbGeAlD
Sunitinib—MAP2K5—head—Parkinson's disease	6.94e-05	0.000546	CbGeAlD
Sunitinib—STK10—cerebellum—Parkinson's disease	6.93e-05	0.000546	CbGeAlD
Sunitinib—PDGFRB—midbrain—Parkinson's disease	6.92e-05	0.000545	CbGeAlD
Sunitinib—IRAK1—brain—Parkinson's disease	6.92e-05	0.000545	CbGeAlD
Sunitinib—KIT—spinal cord—Parkinson's disease	6.92e-05	0.000545	CbGeAlD
Sunitinib—TAOK3—cerebellum—Parkinson's disease	6.9e-05	0.000544	CbGeAlD
Sunitinib—PDGFRA—cerebellum—Parkinson's disease	6.86e-05	0.00054	CbGeAlD
Sunitinib—RPS6KB1—brain—Parkinson's disease	6.79e-05	0.000535	CbGeAlD
Sunitinib—CSF1R—head—Parkinson's disease	6.77e-05	0.000533	CbGeAlD
Sunitinib—PDGFRB—spinal cord—Parkinson's disease	6.75e-05	0.000532	CbGeAlD
Sunitinib—RET—brain—Parkinson's disease	6.75e-05	0.000532	CbGeAlD
Sunitinib—FGR—brain—Parkinson's disease	6.75e-05	0.000532	CbGeAlD
Sunitinib—AXL—brain—Parkinson's disease	6.72e-05	0.00053	CbGeAlD
Sunitinib—KCNH2—forebrain—Parkinson's disease	6.62e-05	0.000522	CbGeAlD
Sunitinib—KDR—nervous system—Parkinson's disease	6.58e-05	0.000518	CbGeAlD
Sunitinib—MAP2K5—nervous system—Parkinson's disease	6.58e-05	0.000518	CbGeAlD
Sunitinib—SLK—brain—Parkinson's disease	6.47e-05	0.00051	CbGeAlD
Sunitinib—CSF1R—nervous system—Parkinson's disease	6.42e-05	0.000505	CbGeAlD
Sunitinib—FGFR2—brain—Parkinson's disease	6.41e-05	0.000505	CbGeAlD
Sunitinib—JAK2—brain—Parkinson's disease	6.38e-05	0.000502	CbGeAlD
Sunitinib—MAP2K5—central nervous system—Parkinson's disease	6.33e-05	0.000499	CbGeAlD
Sunitinib—KDR—central nervous system—Parkinson's disease	6.33e-05	0.000499	CbGeAlD
Sunitinib—FYN—brain—Parkinson's disease	6.29e-05	0.000496	CbGeAlD
Sunitinib—KDR—cerebellum—Parkinson's disease	6.19e-05	0.000487	CbGeAlD
Sunitinib—MAP2K5—cerebellum—Parkinson's disease	6.19e-05	0.000487	CbGeAlD
Sunitinib—CSF1R—central nervous system—Parkinson's disease	6.18e-05	0.000487	CbGeAlD
Sunitinib—MAP4K5—brain—Parkinson's disease	6.15e-05	0.000484	CbGeAlD
Sunitinib—MAP3K3—brain—Parkinson's disease	6.15e-05	0.000484	CbGeAlD
Sunitinib—KIT—head—Parkinson's disease	6.15e-05	0.000484	CbGeAlD
Sunitinib—CSF1R—cerebellum—Parkinson's disease	6.04e-05	0.000476	CbGeAlD
Sunitinib—PDGFRB—head—Parkinson's disease	6e-05	0.000473	CbGeAlD
Sunitinib—FLT1—brain—Parkinson's disease	5.95e-05	0.000468	CbGeAlD
Sunitinib—EPHB6—brain—Parkinson's disease	5.88e-05	0.000463	CbGeAlD
Sunitinib—KIT—nervous system—Parkinson's disease	5.83e-05	0.000459	CbGeAlD
Sunitinib—PDGFRB—nervous system—Parkinson's disease	5.69e-05	0.000448	CbGeAlD
Sunitinib—YES1—brain—Parkinson's disease	5.68e-05	0.000447	CbGeAlD
Sunitinib—STK10—brain—Parkinson's disease	5.63e-05	0.000443	CbGeAlD
Sunitinib—KIT—central nervous system—Parkinson's disease	5.61e-05	0.000442	CbGeAlD
Sunitinib—TAOK3—brain—Parkinson's disease	5.61e-05	0.000442	CbGeAlD
Sunitinib—KCNH2—cardiovascular system—Parkinson's disease	5.6e-05	0.000441	CbGeAlD
Sunitinib—PDGFRA—brain—Parkinson's disease	5.57e-05	0.000439	CbGeAlD
Sunitinib—KIT—cerebellum—Parkinson's disease	5.48e-05	0.000432	CbGeAlD
Sunitinib—PDGFRB—central nervous system—Parkinson's disease	5.48e-05	0.000432	CbGeAlD
Sunitinib—PDGFRB—cerebellum—Parkinson's disease	5.36e-05	0.000422	CbGeAlD
Sunitinib—KDR—brain—Parkinson's disease	5.03e-05	0.000396	CbGeAlD
Sunitinib—MAP2K5—brain—Parkinson's disease	5.03e-05	0.000396	CbGeAlD
Sunitinib—CSF1R—brain—Parkinson's disease	4.91e-05	0.000386	CbGeAlD
Sunitinib—KCNH2—medulla oblongata—Parkinson's disease	4.79e-05	0.000377	CbGeAlD
Sunitinib—ABCC4—head—Parkinson's disease	4.78e-05	0.000376	CbGeAlD
Sunitinib—ABCC4—nervous system—Parkinson's disease	4.53e-05	0.000357	CbGeAlD
Sunitinib—KIT—brain—Parkinson's disease	4.45e-05	0.000351	CbGeAlD
Sunitinib—KCNH2—midbrain—Parkinson's disease	4.37e-05	0.000344	CbGeAlD
Sunitinib—ABCC4—central nervous system—Parkinson's disease	4.36e-05	0.000344	CbGeAlD
Sunitinib—PDGFRB—brain—Parkinson's disease	4.35e-05	0.000343	CbGeAlD
Sunitinib—KCNH2—spinal cord—Parkinson's disease	4.27e-05	0.000336	CbGeAlD
Sunitinib—ABCG2—medulla oblongata—Parkinson's disease	4.26e-05	0.000335	CbGeAlD
Sunitinib—ABCG2—midbrain—Parkinson's disease	3.89e-05	0.000306	CbGeAlD
Sunitinib—ABCG2—spinal cord—Parkinson's disease	3.8e-05	0.000299	CbGeAlD
Sunitinib—KCNH2—head—Parkinson's disease	3.79e-05	0.000299	CbGeAlD
Sunitinib—KCNH2—nervous system—Parkinson's disease	3.6e-05	0.000283	CbGeAlD
Sunitinib—ABCC4—brain—Parkinson's disease	3.46e-05	0.000273	CbGeAlD
Sunitinib—KCNH2—central nervous system—Parkinson's disease	3.46e-05	0.000273	CbGeAlD
Sunitinib—KCNH2—cerebellum—Parkinson's disease	3.38e-05	0.000266	CbGeAlD
Sunitinib—ABCB1—embryo—Parkinson's disease	3.29e-05	0.000259	CbGeAlD
Sunitinib—ABCG2—cerebellum—Parkinson's disease	3.01e-05	0.000237	CbGeAlD
Sunitinib—ABCB1—forebrain—Parkinson's disease	2.91e-05	0.000229	CbGeAlD
Sunitinib—KCNH2—brain—Parkinson's disease	2.75e-05	0.000216	CbGeAlD
Sunitinib—ABCB1—cardiovascular system—Parkinson's disease	2.46e-05	0.000193	CbGeAlD
Sunitinib—ABCG2—brain—Parkinson's disease	2.45e-05	0.000193	CbGeAlD
Sunitinib—CYP3A4—nervous system—Parkinson's disease	2.23e-05	0.000175	CbGeAlD
Sunitinib—CYP3A4—central nervous system—Parkinson's disease	2.15e-05	0.000169	CbGeAlD
Sunitinib—ABCB1—medulla oblongata—Parkinson's disease	2.1e-05	0.000165	CbGeAlD
Sunitinib—ABCB1—midbrain—Parkinson's disease	1.92e-05	0.000151	CbGeAlD
Sunitinib—ABCB1—spinal cord—Parkinson's disease	1.87e-05	0.000147	CbGeAlD
Sunitinib—ABCB1—head—Parkinson's disease	1.66e-05	0.000131	CbGeAlD
Sunitinib—ABCB1—nervous system—Parkinson's disease	1.58e-05	0.000124	CbGeAlD
Sunitinib—ABCB1—central nervous system—Parkinson's disease	1.52e-05	0.00012	CbGeAlD
Sunitinib—ABCB1—cerebellum—Parkinson's disease	1.48e-05	0.000117	CbGeAlD
Sunitinib—ABCB1—brain—Parkinson's disease	1.21e-05	9.49e-05	CbGeAlD
Sunitinib—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.36e-06	7.72e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—DBH—Parkinson's disease	1.36e-06	7.72e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GBA—Parkinson's disease	1.36e-06	7.72e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF2—Parkinson's disease	1.36e-06	7.7e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EDN1—Parkinson's disease	1.36e-06	7.69e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL1B—Parkinson's disease	1.36e-06	7.68e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—INS—Parkinson's disease	1.36e-06	7.67e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—APOE—Parkinson's disease	1.35e-06	7.65e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—APOE—Parkinson's disease	1.35e-06	7.65e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—CASP3—Parkinson's disease	1.35e-06	7.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—INS—Parkinson's disease	1.35e-06	7.63e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	1.35e-06	7.62e-06	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—IL6—Parkinson's disease	1.34e-06	7.6e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ABCB1—Parkinson's disease	1.34e-06	7.6e-06	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—IL6—Parkinson's disease	1.34e-06	7.59e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—IL6—Parkinson's disease	1.34e-06	7.59e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CASP3—Parkinson's disease	1.34e-06	7.58e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NGF—Parkinson's disease	1.34e-06	7.56e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL1B—Parkinson's disease	1.33e-06	7.55e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL1B—Parkinson's disease	1.33e-06	7.55e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ABCB1—Parkinson's disease	1.33e-06	7.53e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—IL6—Parkinson's disease	1.33e-06	7.53e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—IL6—Parkinson's disease	1.33e-06	7.51e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MAPK8—Parkinson's disease	1.32e-06	7.49e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CTGF—Parkinson's disease	1.32e-06	7.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1R—Parkinson's disease	1.32e-06	7.44e-06	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	7.42e-06	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	7.42e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—GSTM1—Parkinson's disease	1.3e-06	7.38e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NGF—Parkinson's disease	1.3e-06	7.37e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EDN1—Parkinson's disease	1.3e-06	7.35e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—MAPK8—Parkinson's disease	1.3e-06	7.35e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—INS—Parkinson's disease	1.29e-06	7.32e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—GSTM1—Parkinson's disease	1.29e-06	7.31e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—INS—Parkinson's disease	1.29e-06	7.3e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—APOE—Parkinson's disease	1.28e-06	7.26e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—APOE—Parkinson's disease	1.28e-06	7.24e-06	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—IL6—Parkinson's disease	1.27e-06	7.2e-06	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IL6—Parkinson's disease	1.27e-06	7.2e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HTR2A—Parkinson's disease	1.27e-06	7.19e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—IL6—Parkinson's disease	1.27e-06	7.18e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL1B—Parkinson's disease	1.27e-06	7.16e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL1B—Parkinson's disease	1.26e-06	7.14e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—MAPK8—Parkinson's disease	1.26e-06	7.13e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NGF—Parkinson's disease	1.26e-06	7.11e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NGF—Parkinson's disease	1.25e-06	7.07e-06	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL6—Parkinson's disease	1.25e-06	7.07e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—GPX1—Parkinson's disease	1.25e-06	7.06e-06	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—IL6—Parkinson's disease	1.25e-06	7.06e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—MAPK8—Parkinson's disease	1.25e-06	7.05e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MAPK8—Parkinson's disease	1.24e-06	7.03e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—IL6—Parkinson's disease	1.24e-06	7.02e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HTR2A—Parkinson's disease	1.24e-06	7.02e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—GPX1—Parkinson's disease	1.24e-06	7e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	1.23e-06	6.97e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MAPK8—Parkinson's disease	1.23e-06	6.96e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—INS—Parkinson's disease	1.23e-06	6.94e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CASP3—Parkinson's disease	1.23e-06	6.94e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—MAPK8—Parkinson's disease	1.22e-06	6.92e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—MAPK8—Parkinson's disease	1.22e-06	6.92e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NQO1—Parkinson's disease	1.22e-06	6.89e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL6—Parkinson's disease	1.22e-06	6.88e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—IL6—Parkinson's disease	1.21e-06	6.83e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—TH—Parkinson's disease	1.2e-06	6.79e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HTR2A—Parkinson's disease	1.2e-06	6.77e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NGF—Parkinson's disease	1.19e-06	6.76e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—INS—Parkinson's disease	1.19e-06	6.74e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HTR2A—Parkinson's disease	1.19e-06	6.73e-06	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—IL6—Parkinson's disease	1.19e-06	6.71e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—APOE—Parkinson's disease	1.18e-06	6.69e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CASP3—Parkinson's disease	1.18e-06	6.69e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—INS—Parkinson's disease	1.18e-06	6.66e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CASP3—Parkinson's disease	1.17e-06	6.64e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL6—Parkinson's disease	1.17e-06	6.64e-06	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL6—Parkinson's disease	1.17e-06	6.64e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—IL6—Parkinson's disease	1.17e-06	6.63e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1B—Parkinson's disease	1.17e-06	6.59e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—MAPK8—Parkinson's disease	1.16e-06	6.57e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—MAPK8—Parkinson's disease	1.16e-06	6.55e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—INS—Parkinson's disease	1.16e-06	6.54e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—INS—Parkinson's disease	1.16e-06	6.54e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—APOE—Parkinson's disease	1.15e-06	6.53e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYCS—Parkinson's disease	1.15e-06	6.52e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—MTHFR—Parkinson's disease	1.15e-06	6.52e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—IL6—Parkinson's disease	1.14e-06	6.47e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—MTHFR—Parkinson's disease	1.14e-06	6.46e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CASP3—Parkinson's disease	1.14e-06	6.44e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CASP3—Parkinson's disease	1.14e-06	6.44e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1B—Parkinson's disease	1.14e-06	6.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HTR2A—Parkinson's disease	1.14e-06	6.43e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MAPK8—Parkinson's disease	1.13e-06	6.38e-06	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL6—Parkinson's disease	1.11e-06	6.3e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—APOE—Parkinson's disease	1.11e-06	6.29e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CASP3—Parkinson's disease	1.11e-06	6.28e-06	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL6—Parkinson's disease	1.11e-06	6.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—APOE—Parkinson's disease	1.11e-06	6.26e-06	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—IL6—Parkinson's disease	1.1e-06	6.24e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL6—Parkinson's disease	1.1e-06	6.21e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—INS—Parkinson's disease	1.1e-06	6.2e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1B—Parkinson's disease	1.1e-06	6.2e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—IL6—Parkinson's disease	1.1e-06	6.2e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—INS—Parkinson's disease	1.09e-06	6.19e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1B—Parkinson's disease	1.09e-06	6.17e-06	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL6—Parkinson's disease	1.09e-06	6.15e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MAPK8—Parkinson's disease	1.09e-06	6.15e-06	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL6—Parkinson's disease	1.08e-06	6.13e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MAPK8—Parkinson's disease	1.08e-06	6.11e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—APOE—Parkinson's disease	1.07e-06	6.07e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—MAPK8—Parkinson's disease	1.07e-06	6.05e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—APOE—Parkinson's disease	1.06e-06	6.01e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—APOE—Parkinson's disease	1.06e-06	5.98e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—Parkinson's disease	1.05e-06	5.93e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MAPK8—Parkinson's disease	1.05e-06	5.92e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MAPK8—Parkinson's disease	1.05e-06	5.92e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—Parkinson's disease	1.05e-06	5.92e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—MAPK8—Parkinson's disease	1.04e-06	5.9e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—Parkinson's disease	1.04e-06	5.9e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—COMT—Parkinson's disease	1.02e-06	5.78e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MAPK8—Parkinson's disease	1.02e-06	5.77e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.02e-06	5.75e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.02e-06	5.75e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.01e-06	5.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—INS—Parkinson's disease	1.01e-06	5.71e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—MAPK8—Parkinson's disease	1.01e-06	5.69e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1e-06	5.67e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—DDC—Parkinson's disease	1e-06	5.67e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—MAPK8—Parkinson's disease	1e-06	5.66e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CTGF—Parkinson's disease	9.98e-07	5.65e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—Parkinson's disease	9.87e-07	5.58e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—INS—Parkinson's disease	9.86e-07	5.58e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—Parkinson's disease	9.79e-07	5.54e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CASP3—Parkinson's disease	9.64e-07	5.45e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ABCB1—Parkinson's disease	9.62e-07	5.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—MAPK8—Parkinson's disease	9.56e-07	5.41e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—INS—Parkinson's disease	9.5e-07	5.37e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.46e-07	5.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—INS—Parkinson's disease	9.45e-07	5.35e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GSTM1—Parkinson's disease	9.34e-07	5.28e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP2E1—Parkinson's disease	9.3e-07	5.26e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NQO1—Parkinson's disease	9.2e-07	5.2e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—INS—Parkinson's disease	9.16e-07	5.18e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CASP3—Parkinson's disease	9.14e-07	5.17e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—INS—Parkinson's disease	9.08e-07	5.14e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TH—Parkinson's disease	9.06e-07	5.13e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—INS—Parkinson's disease	9.03e-07	5.11e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GPX1—Parkinson's disease	8.95e-07	5.06e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CASP3—Parkinson's disease	8.87e-07	5.02e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK8—Parkinson's disease	8.86e-07	5.01e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—Parkinson's disease	8.81e-07	4.99e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CASP3—Parkinson's disease	8.76e-07	4.96e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—Parkinson's disease	8.75e-07	4.95e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYCS—Parkinson's disease	8.7e-07	4.92e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CASP3—Parkinson's disease	8.61e-07	4.87e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CASP3—Parkinson's disease	8.61e-07	4.87e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.52e-07	4.82e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—Parkinson's disease	8.46e-07	4.78e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.43e-07	4.77e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK8—Parkinson's disease	8.4e-07	4.75e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—Parkinson's disease	8.3e-07	4.69e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTHFR—Parkinson's disease	8.26e-07	4.67e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CASP3—Parkinson's disease	8.17e-07	4.62e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK8—Parkinson's disease	8.15e-07	4.61e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CASP3—Parkinson's disease	8.15e-07	4.61e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—Parkinson's disease	8.05e-07	4.56e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK8—Parkinson's disease	8.05e-07	4.56e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—Parkinson's disease	7.95e-07	4.5e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—Parkinson's disease	7.93e-07	4.49e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK8—Parkinson's disease	7.91e-07	4.47e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK8—Parkinson's disease	7.91e-07	4.47e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—Parkinson's disease	7.86e-07	4.45e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—Parkinson's disease	7.81e-07	4.42e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—Parkinson's disease	7.81e-07	4.42e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—COMT—Parkinson's disease	7.71e-07	4.36e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOE—Parkinson's disease	7.69e-07	4.35e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTP1—Parkinson's disease	7.67e-07	4.34e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MAOA—Parkinson's disease	7.65e-07	4.33e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HMOX1—Parkinson's disease	7.57e-07	4.28e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CASP3—Parkinson's disease	7.52e-07	4.25e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK8—Parkinson's disease	7.51e-07	4.25e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK8—Parkinson's disease	7.49e-07	4.23e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—Parkinson's disease	7.47e-07	4.23e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—Parkinson's disease	7.44e-07	4.21e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—Parkinson's disease	7.41e-07	4.19e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—Parkinson's disease	7.39e-07	4.18e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—Parkinson's disease	7.34e-07	4.15e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CASP3—Parkinson's disease	7.34e-07	4.15e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—Parkinson's disease	7.21e-07	4.08e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—Parkinson's disease	7.2e-07	4.07e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CASP3—Parkinson's disease	7.07e-07	4e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—Parkinson's disease	7.05e-07	3.99e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CASP3—Parkinson's disease	7.04e-07	3.98e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—Parkinson's disease	6.99e-07	3.95e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—Parkinson's disease	6.94e-07	3.92e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK8—Parkinson's disease	6.91e-07	3.91e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—Parkinson's disease	6.89e-07	3.9e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—Parkinson's disease	6.84e-07	3.87e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—Parkinson's disease	6.83e-07	3.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—Parkinson's disease	6.83e-07	3.86e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—Parkinson's disease	6.75e-07	3.82e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK8—Parkinson's disease	6.74e-07	3.82e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—Parkinson's disease	6.72e-07	3.8e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—Parkinson's disease	6.68e-07	3.78e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—Parkinson's disease	6.68e-07	3.78e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—Parkinson's disease	6.68e-07	3.78e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—Parkinson's disease	6.66e-07	3.77e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—INS—Parkinson's disease	6.57e-07	3.71e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—Parkinson's disease	6.51e-07	3.68e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK8—Parkinson's disease	6.5e-07	3.68e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK8—Parkinson's disease	6.47e-07	3.66e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—Parkinson's disease	6.42e-07	3.63e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—Parkinson's disease	6.39e-07	3.61e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—Parkinson's disease	6.3e-07	3.57e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.27e-07	3.54e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—Parkinson's disease	6.23e-07	3.52e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK8—Parkinson's disease	6.18e-07	3.5e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—Parkinson's disease	6.15e-07	3.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.15e-07	3.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—Parkinson's disease	6.1e-07	3.45e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—Parkinson's disease	5.93e-07	3.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—Parkinson's disease	5.9e-07	3.34e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—Parkinson's disease	5.8e-07	3.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.73e-07	3.24e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.67e-07	3.21e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—Parkinson's disease	5.66e-07	3.2e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—Parkinson's disease	5.64e-07	3.19e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TH—Parkinson's disease	5.58e-07	3.16e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—Parkinson's disease	5.36e-07	3.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.36e-07	3.03e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—Parkinson's disease	5.21e-07	2.95e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—Parkinson's disease	5.14e-07	2.91e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—Parkinson's disease	5.05e-07	2.86e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—Parkinson's disease	5.05e-07	2.86e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—INS—Parkinson's disease	4.95e-07	2.8e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—Parkinson's disease	4.79e-07	2.71e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—Parkinson's disease	4.78e-07	2.7e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—COMT—Parkinson's disease	4.75e-07	2.69e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.73e-07	2.67e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.72e-07	2.67e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.66e-07	2.64e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.47e-07	2.53e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—Parkinson's disease	4.41e-07	2.5e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.34e-07	2.46e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—Parkinson's disease	4.31e-07	2.44e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.16e-07	2.35e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—Parkinson's disease	4.15e-07	2.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—Parkinson's disease	4.13e-07	2.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—Parkinson's disease	3.95e-07	2.23e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.84e-07	2.17e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—Parkinson's disease	3.57e-07	2.02e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—INS—Parkinson's disease	3.05e-07	1.73e-06	CbGpPWpGaD
